318 related articles for article (PubMed ID: 26683776)
1. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.
Zeng ZL; Luo HY; Yang J; Wu WJ; Chen DL; Huang P; Xu RH
Clin Cancer Res; 2014 Feb; 20(4):1042-52. PubMed ID: 24277452
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
4. The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance.
Jiang W; Zhao S; Shen J; Guo L; Sun Y; Zhu Y; Ma Z; Zhang X; Hu Y; Xiao W; Li K; Li S; Zhou L; Huang L; Lu Z; Feng Y; Xiao J; Zhang EE; Yang L; Wan R
Cell Death Dis; 2018 Feb; 9(2):149. PubMed ID: 29396463
[TBL] [Abstract][Full Text] [Related]
5. Circadian clock gene
Zhao C; Meng X; Li Y; Liu L; He Q; Jiang J; Chen Y; Li X; Li Y; Tang Y; Zhou D; Zhou J; Jin F
Chronobiol Int; 2022 Oct; 39(10):1340-1351. PubMed ID: 35903031
[No Abstract] [Full Text] [Related]
6. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
7. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
8. BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways.
Zhang Y; Devocelle A; Souza L; Foudi A; Tenreira Bento S; Desterke C; Sherrard R; Ballesta A; Adam R; Giron-Michel J; Chang Y
Aging (Albany NY); 2020 May; 12(9):8067-8083. PubMed ID: 32388500
[TBL] [Abstract][Full Text] [Related]
9. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity.
Zeng ZL; Wu MW; Sun J; Sun YL; Cai YC; Huang YJ; Xian LJ
J Biochem; 2010 Sep; 148(3):319-26. PubMed ID: 20576619
[TBL] [Abstract][Full Text] [Related]
10. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
[TBL] [Abstract][Full Text] [Related]
11. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells.
Lin F; Chen Y; Li X; Zhao Q; Tan Z
Cell Biochem Funct; 2013 Mar; 31(2):166-72. PubMed ID: 22961668
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
[TBL] [Abstract][Full Text] [Related]
14. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
[TBL] [Abstract][Full Text] [Related]
15. Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma.
Tang Q; Cheng B; Xie M; Chen Y; Zhao J; Zhou X; Chen L
Cancer Res; 2017 Jan; 77(2):532-544. PubMed ID: 27821487
[TBL] [Abstract][Full Text] [Related]
16. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C; Jia W; Tang Y; Zhao H; Jiang Y; Sun S
J Exp Clin Cancer Res; 2012 Oct; 31(1):84. PubMed ID: 23034174
[TBL] [Abstract][Full Text] [Related]
19. Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.
Zhang S; Zhang J; Deng Z; Liu H; Mao W; Jiang F; Xia Z; Li JD
Oncotarget; 2016 Oct; 7(40):66087-66099. PubMed ID: 27602774
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.
Du Y; Liu Z; You L; Hou P; Ren X; Jiao T; Zhao W; Li Z; Shu H; Liu C; Zhao Y
Cancer Res; 2017 May; 77(10):2661-2673. PubMed ID: 28280038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
